banner image

Investor FAQs

Where is IBS Inc.'s corporate headquarters?
142 West 57TH Street, 9th Fl., New York, NY 10019
Where is the company incorporated?
The company is incorporated under the laws of the State of Delaware.
When did IBS Inc. go public and what was the price?
IBS Inc. began trading on the Nasdaq Global Market on December 22, 2020. The initial price was $17.00 per share.
What is IBS Inc.’s fiscal year?
IBS Inc’s fiscal year-end is June 30.
How is IBS Inc. stock traded?
IBS Inc. is traded on the Nasdaq Global Market under the tick symbol INBS and the CUSIP number 36151G 105.
Who is IBS Inc.'s transfer agent?
Continental Stock Transfer & Trust Company
1 State Street, 30th Floor
New York, NY 10004-1561
T: 212 509 4000
E: cstmail@continentalstock.com
Whom do I contact with questions about my stock?
For questions about your stock, please contact our transfer agency, Continental Stock Transfer & Trust Company.
Does IBS Inc. have a direct stock purchase plan?
IBS Inc. does not have a direct stock purchase plan. Shares can be purchased through a stockbroker of your choice.
Who is IBS Inc.'s auditor?
BDO Audit Pty Ltd.
Who is IBS Inc.'s legal counsel?
ArentFox Schiff
How can I view documents IBS Inc. has filed with the Securities & Exchange Commission (SEC), including Forms 10-K and 10-Q?
Company filings can be accessed via the SEC’s website link https://www.sec.gov by searching for
IBS Inc.
CIK Code: 0001725430
Where can I find out more about IBS Inc.?
Please visit IBS Inc.’s website at https://ibs.inc/
Where can I get the latest corporate news releases?
Corporate news can be found in the Press Release section of our Investors webpage.
Whom should I contact regarding investor inquiries?
Please contact KCSA Strategic Communications at INBS@kcsa.com.